⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VTRS News
Viatris Inc. Common Stock
Viatris to Outline its Vision for Sustained Revenue and Earnings Growth Through 2030
prnewswire.com
VTRS
Blue Matter lance une pratique d'expertise en ressources humaines et organisationnelles pour accompagner les entreprises biopharmaceutiques dans leur transformation structurelle
businesswire.com
VTRS
PGR
BHC
Blue Matter führt die People and Organization Practice ein, um Biopharma-Unternehmen bei der Bewältigung des Strukturwandels zu unterstützen
businesswire.com
VTRS
PERI
Blue Matter Launches People and Organization Practice to Help Biopharma Navigate Structural Shift
businesswire.com
BHC
VTRS
PERI
Form 8-K
sec.gov
VTRS
Viatris Reports Fourth-Quarter and Full-Year 2025 Financial Results
prnewswire.com
VTRS
Viatris Maintains Dividend Policy for 2026 and Announces Quarterly Dividend
prnewswire.com
VTRS
Idorsia reports strong 2025 results with QUVIVIQ sales more than doubling – further sales growth ahead with multiple pipeline catalysts in 2026
globenewswire.com
VTRS
Global Ophthalmic Drugs Market Estimated at US$41.88 Billion in 2026; Projected to Grow at 7.9% CAGR Through 2036
globenewswire.com
ABBV
ALC
APLS
BHC
JNJ
PFE
REGN
TEVA
VTRS
Opus Genetics Announces FDA Acceptance of Supplemental New Drug Application for Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia
globenewswire.com
IRD
VTRS